- Home
- CUBA vs ANEB Comparison
CUBA vs ANEB Comparison
Compare CUBA & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUBA
- ANEB
- Stock Information
- Founded
- CUBA 1992
- ANEB 2020
- Country
- CUBA United States
- ANEB United States
- Employees
- CUBA N/A
- ANEB N/A
- Industry
- CUBA Investment Managers
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- CUBA Finance
- ANEB Health Care
- Exchange
- CUBA Nasdaq
- ANEB Nasdaq
- Market Cap
- CUBA 39.6M
- ANEB 36.7M
- IPO Year
- CUBA N/A
- ANEB 2021
- Fundamental
- Price
- CUBA $2.45
- ANEB $1.59
- Analyst Decision
- CUBA
- ANEB Buy
- Analyst Count
- CUBA 0
- ANEB 1
- Target Price
- CUBA N/A
- ANEB $8.00
- AVG Volume (30 Days)
- CUBA 93.9K
- ANEB 60.6K
- Earning Date
- CUBA 01-01-0001
- ANEB 02-11-2025
- Dividend Yield
- CUBA 20.83%
- ANEB N/A
- EPS Growth
- CUBA N/A
- ANEB N/A
- EPS
- CUBA N/A
- ANEB N/A
- Revenue
- CUBA N/A
- ANEB N/A
- Revenue This Year
- CUBA N/A
- ANEB N/A
- Revenue Next Year
- CUBA N/A
- ANEB N/A
- P/E Ratio
- CUBA N/A
- ANEB N/A
- Revenue Growth
- CUBA N/A
- ANEB N/A
- 52 Week Low
- CUBA $2.25
- ANEB $0.80
- 52 Week High
- CUBA $4.14
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- CUBA 53.72
- ANEB 51.06
- Support Level
- CUBA $2.41
- ANEB $1.52
- Resistance Level
- CUBA $2.48
- ANEB $1.69
- Average True Range (ATR)
- CUBA 0.06
- ANEB 0.13
- MACD
- CUBA 0.01
- ANEB 0.00
- Stochastic Oscillator
- CUBA 50.00
- ANEB 52.00
About CUBA Herzfeld Caribbean Basin Fund Inc. (The)
Herzfeld Caribbean Basin Fund Inc operates as a closed-end management investment company. The company's investment objective is to obtain long-term capital appreciation. The firm offers customized discretionary account management and fund management services to individual and institutional investors. The fund invests in equity and equity-linked securities of public and private companies, including United States-based companies, whose securities are traded principally on a stock exchange in a Caribbean Basin Country. The fund's revenue source is through the dividends it receives. Its investments are geographically allocated in the United States followed by Mexico, Puerto Rico, and other countries.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.